Henri Termeer

Henri Termeer has served as a director of AVEO since April 2011 and is Chairman of the Board. He served as chairman, president and chief executive officer of Genzyme Corporation for nearly three decades.

Henri Termeer was appointed president of Genzyme in 1983, two years after the company's founding. He became its chief executive officer in 1985 and chairman in 1988. He retired from Genzyme in June 2011 following the acquisition of Genzyme by Sanofi in a transaction valued at more than $20 billion.

In 2008, he was appointed to Massachusetts Governor Deval Patrick’s Council of Economic Advisors, and he is a co-chair of the Leadership Council of the Massachusetts Life Sciences Collaborative.

Henri Termeer is also Chairman Emeritus of the New England Healthcare Institute, a nonprofit, applied research health policy organization he was instrumental in founding.Henri Termeer was Chairman of the Federal Reserve Bank of Boston’s Board of Directors from 2010-2011. He is a board member of ABIOMED Inc., Verastem, Inc. and Medical Simulation.

Henri Termeer is a Board member of Massachusetts Institute of Technology Corporation and serves on its Executive Committee, is a director of Massachusetts General Hospital, a Board member of Partners HealthCare and a member of the Board of Fellows of Harvard Medical School.

He served on the Board of Directors of the Pharmaceutical Research and Manufacturers of America.

Henri Termeer studied economics at the Economische Hogeschool (Erasmus University, The Netherlands) and earned an M.B.A from the Darden School at the University of Virginia.

Henri Termeer is the Founder at Lysosomal Therapeutics, based in Europe. With a background in Biotechnology, Henri Termeer has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.